메뉴 건너뛰기
Turkish Journal of Gastroenterology
Volumn 21, Issue 3, 2010, Pages 313-316
A case of gynecomastia due to entecavir
Author keywords

Antiretroviral treatment; Chronic hepatitis B; Entecavir; Gynecomastia; Nucleoside analogs
Indexed keywords

ALANINE AMINOTRANSFERASE; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; INDAPAMIDE PLUS PERINDOPRIL; PEGINTERFERON ALPHA2A; VIRUS DNA;
EID: 77957678995     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2010.0108     Document Type: Article
Times cited : (4)
References (7)
  • 1
    • 34548849816 scopus 로고    scopus 로고
    • Clinical practise. Gynecomastia
    • Braunstein MD. Clinical practise. Gynecomastia. N Engl J Med 2007; 357: 1229-37.
    • (2007) N Engl J Med , vol.357 , pp. 1229-1237
    • Braunstein, M.D.1
  • 2
    • 3042634451 scopus 로고    scopus 로고
    • Gynecomastia and potent antiretroviral therapy
    • Swiss HIV Cohort Study
    • Strub C, Kaufmann GR, Flepp M, et al; Swiss HIV Cohort Study. Gynecomastia and potent antiretroviral therapy. AIDS 2004; 18: 1347-49.
    • (2004) AIDS , vol.18 , pp. 1347-1349
    • Strub, C.1    Kaufmann, G.R.2    Flepp, M.3
  • 3
    • 2642534354 scopus 로고    scopus 로고
    • Efavirenz-associated gynecomastia: Report of five cases and review of the literature
    • Jover F, Cuadrado JM, Roig P, et al. Efavirenz-associated gynecomastia: report of five cases and review of the literature. Breast J 2004; 10: 244-6.
    • (2004) Breast J , vol.10 , pp. 244-246
    • Jover, F.1    Cuadrado, J.M.2    Roig, P.3
  • 4
    • 35649020315 scopus 로고    scopus 로고
    • Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B
    • Gish RG, Lok AS, Chang TT, et al. Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. Gastroenterology 2007; 133: 1437-44.
    • (2007) Gastroenterology , vol.133 , pp. 1437-1444
    • Gish, R.G.1    Lok, A.S.2    Chang, T.T.3
  • 5
    • 33644822860 scopus 로고    scopus 로고
    • Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    • BEHoLD AI463027 Study Group
    • Lai CL, Shouval D, Lok AS, et al; BEHoLD AI463027 Study Group. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2006; 354: 1011-20.
    • (2006) N Engl J Med , vol.354 , pp. 1011-1020
    • Lai, C.L.1    Shouval, D.2    Lok, A.S.3
  • 6
    • 33746339209 scopus 로고    scopus 로고
    • A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: An update. Review
    • Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Review. Clin Gastroenterol Hepatol 2006; 4: 936-62.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 936-962
    • Keeffe, E.B.1    Dieterich, D.T.2    Han, S.H.3
  • 7
    • 0034990695 scopus 로고    scopus 로고
    • Entecavir (Bristol-Myers Squibb)
    • Billich A. Entecavir (Bristol-Myers Squibb). Curr Opin Investig Drugs 2001; 2: 617-21.
    • (2001) Curr Opin Investig Drugs , vol.2 , pp. 617-621
    • Billich, A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.